APA (7th ed.) Citation

JN, G., TM, D., DM, M., G, P., T, K., LP, Z., . . . DCS, H. (2025). Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins. Cell death and differentiation, 32(8), 1382. https://doi.org/10.1038/s41418-025-01487-7

Chicago Style (17th ed.) Citation

JN, Gong, et al. "Re-appraising Assays on Permeabilized Blood Cancer Cells Testing Venetoclax or Other BH3 Mimetic Agents Selectively Targeting Pro-survival BCL2 Proteins." Cell Death and Differentiation 32, no. 8 (2025): 1382. https://doi.org/10.1038/s41418-025-01487-7.

MLA (9th ed.) Citation

JN, Gong, et al. "Re-appraising Assays on Permeabilized Blood Cancer Cells Testing Venetoclax or Other BH3 Mimetic Agents Selectively Targeting Pro-survival BCL2 Proteins." Cell Death and Differentiation, vol. 32, no. 8, 2025, p. 1382, https://doi.org/10.1038/s41418-025-01487-7.